⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12891807 | 1.00 | — | — | |
| SCHEMBL7638382 | 1.00 | — | — | |
| SCHEMBL8025988 | 1.00 | — | — | |
| SCHEMBL6117957 | 1.00 | — | — | |
| SCHEMBL1952619 | 1.00 | — | — | |
| SCHEMBL13757668 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL29179689 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL2450453 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL1255380 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL4555952 | 0.98 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2028186-B1 | Hepatitis C inhibitor tri-peptides | BOEHRINGER INGELHEIM CA LTD (CA) | 2013-01-23 | — | — | EP | claimed |
| EP-2028186-A2 | Hepatitis C inhibitor tri-peptides | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2009-02-25 | — | — | EP | claimed |
| CN-1323316-A | Hepatitis C tripeptide inhibitors | BOEHRINGER INGELHEIM CA LTD (CA) | 2001-11-21 | — | — | CN | claimed |
| CN-114714713-B | Weather-resistant PVC decorative film | 江苏万拓新材料科技有限公司 | 2022-12-30 | — | — | CN | disclosed |
| CN-114714713-A | Weather-resistant PVC decorative film | 江苏万拓新材料科技有限公司 | 2022-07-08 | — | — | CN | disclosed |
| CN-105861585-B | A method of hepatitis C NS3 enzyme inhibitor medicine intermediate is split using Sphingomonas | 北京化工大学 | 2019-08-02 | — | — | CN | disclosed |
| CN-105861585-A | Method for splitting hepatitis c NS3 enzyme inhibitor drug intermediate through sphingomonasaquatilis | 北京化工大学 | 2016-08-17 | — | — | CN | disclosed |
| US-9353100-B2 | Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections | IDENIX PHARMACEUTICALS LLC (US) | 2016-05-31 | — | — | US | disclosed |
| EP-2461811-B1 | MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV | IDENIX PHARMACEUTICALS LLC (US) | 2016-04-20 | — | — | EP | disclosed |
| US-9309279-B2 | Macrocyclic hepatitis C serine protease inhibitors | ABBVIE INC. (US) | 2016-04-12 | — | — | US | disclosed |
| US-9284307-B2 | Macrocyclic serine protease inhibitors | IDENIX PHARMACEUTICALS LLC (US) | 2016-03-15 | — | — | US | disclosed |
| US-20090062311-A1 | MACROCYLIC INHIBITORS OF HEPATITIS C VIRUS | JANSSEN SCIENCES IRELAND UC (IE) | 2009-03-05 | — | — | US | disclosed |
| WO-2009005677-A2 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2009-01-08 | — | — | WO | disclosed |
| WO-2008086161-A1 | MACROCYCLIC HEPATITIS C PROTEASE INHIBITORS | PHENOMIX CORPORATION (US) | 2008-07-17 | — | — | WO | disclosed |
| WO-2008057995-A2 | HCV PROTEASE INHIBITORS | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2008-05-15 | — | — | WO | disclosed |
| US-20080108632-A1 | HCV PROTEASE INHIBITORS | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2008-05-08 | — | — | US | disclosed |
| WO-2006043145-A1 | INHIBITORS OF HEPATITIS C VIRUS PROTEASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME | PFIZER INC. (US) | 2006-04-27 | — | — | WO | disclosed |
| US-20040248779-A1 | Process for the preparation of macrocyclic compounds | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-12-09 | — | — | US | disclosed |
| US-6268207-B1 | RESOLUTION OF ENANTIOMERS FROM A MIXTURE OF (1R,2S)/(1S,2S)-1-AMINO-2-VINYLCYCLOPROPYL CARBOXYLIC ACID METHYL ESTER COMPRISING THE STEP OF TREATING SAID MIXTURE WITH AN ESTERASE TO OBTAIN THE CORRESPONDING (1R,2S) ENANTIOMER | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2001-07-31 | — | — | US | disclosed |
| US-6268207-B1 | RESOLUTION OF ENANTIOMERS FROM A MIXTURE OF (1R,2S)/(1S,2S)-1-AMINO-2-VINYLCYCLOPROPYL CARBOXYLIC ACID METHYL ESTER COMPRISING THE STEP OF TREATING SAID MIXTURE WITH AN ESTERASE TO OBTAIN THE CORRESPONDING (1R,2S) ENANTIOMER | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2001-07-31 | — | — | US | disclosed |